MOSCOW — Russian scientists have belatedly published first results from early trials into the experimental Sputnik V vaccine, which received government approval last month but drew considerable criticism from experts, as the shots had only been tested on several dozen people before being more widely administered. In a report published in the...
Virus Crisis Easing Across Sun Belt but Could Heat up Again
The torrid coronavirus summer across the Sun Belt is easing after two disastrous months that brought more than 35,000 deaths. Whether the outbreak will heat up again after Labor Day and the resumption of school and football remains to be seen. Seven of the nine states along the nation's Southern...
Third Virus Vaccine Reaches Major Hurdle: Final US Testing
A handful of the dozens of experimental COVID-19 vaccines in human testing have reached the last and biggest hurdle — looking for the needed proof that they really work as a U.S. advisory panel suggested Tuesday a way to ration the first limited doses once a vaccine wins approval. AstraZeneca...
9 Reasons to Be Optimistic a COVID-19 Vaccine Will Arrive in 2021
As fall approaches rapidly, many are wondering if the race for a vaccine will bear fruit as early as January 2021. I am a physician-scientist and infectious diseases specialist at the University of Virginia, where I care for patients and conduct research into COVID-19. I am occasionally asked how I...
Pharmacists Can Give Childhood Shots, U.S. Officials Say
NEW YORK — Pharmacists in all 50 states are now allowed to give childhood vaccinations under a new directive aimed at preventing future outbreaks of measles and other preventable diseases. Alex Azar, the head of the U.S. Department of Health and Human Services, took the step using emergency powers he...
Who Will Go to the Front of the Line for COVID-19 Vaccine?
The National Governors Association says the availability of a future COVID-19 vaccine will likely be limited due to manufacturing constraints. The NGA issued a memorandum Monday telling state leaders that difficult decisions concerning vaccine allocation and prioritization will occur. Meanwhile, shortages of the antiviral drug remdesivir may give an early indication...
Virus Vaccine Put to Final Test in Thousands of Volunteers
The world’s biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government -- one of several candidates in the final stretch of the global vaccine race. There’s still no guarantee that the experimental vaccine, developed by the National...
UK Coronavirus Vaccine Prompts Immune Response in Early Test
LONDON — Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. British researchers first began testing the vaccine in April in about 1,000 people, half of whom got the...
UK, US, Canada Accuse Russia of Hacking Virus Vaccine Trials
LONDON — Britain, the United States and Canada accused Russia on Thursday of trying to steal information from researchers seeking a COVID-19 vaccine. The three nations alleged that hacking group APT29, also known as Cozy Bear and said to be part of the Russian intelligence service, is attacking academic and...
Global Vaccine Plan May Allow Rich Countries to Buy More
LONDON — Politicians and public health leaders have publicly committed to equitably sharing any coronavirus vaccine that works, but the top global initiative to make that happen may allow rich countries to reinforce their own stockpiles while making fewer doses available for poor ones. Activists warn that without stronger attempts...